Monday, March 28, 2016

Valeant's Outgoing CEO to Testify at Senate Hearing

Michael Pearson, the outgoing chief executive at Valeant Pharmaceuticals is expected to testify next month in front of a Senate committee investigating increases in the prices of certain prescription drugs.

from WSJ.com: US Business http://ift.tt/22VhaOW
via IFTTT

No comments:

Post a Comment